A review of the neurobiological effects of psychotherapy for depression

Psychotherapy

Volumn 47, Issue 4, 2010, Pages 603-615

  Sharpley, Christopher F ^a  

^a UNIVERSITY OF NEW ENGLAND   (Australia)

Author keywords

Depression; Neurobiology; Psycho therapy; Rapport

Indexed keywords

AMYGDALOID NUCLEUS; ARTICLE; BRAIN FUNCTION; DEPRESSION; DOCTOR PATIENT RELATION; HIPPOCAMPUS; HUMAN; MORPHOLOGY; NERVE PROJECTION; NEUROBIOLOGY; NEUROENDOCRINE SYSTEM; PREFRONTAL CORTEX; PSYCHOTHERAPY;

AFFECT; AMYGDALA; BIPOLAR DISORDER; BRAIN; CATECHOLAMINES; CONDITIONING, CLASSICAL; DEPRESSIVE DISORDER, MAJOR; FEAR; HIPPOCAMPUS; HUMANS; HYDROCORTISONE; LIMBIC SYSTEM; NERVE NET; NEURONAL PLASTICITY; OBJECT ATTACHMENT; PREFRONTAL CORTEX; PSYCHOTHERAPY; TREATMENT OUTCOME;

EID: 78651375248     PISSN: 00333204     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0021177     Document Type: Article

References (113)

1. Abercrombie H.C., Schaefer S.M., Larson C.L., Oakes R.T., Lindren K.A., Holden J.A., Davidson R.J. Metabolic rate in the right amygdala predicts negative affect in depressed patients. NeuroReport 1998, 9:3301-3307.
2. Alonso J., Angermeyer M.C., Bernert S., Bruffaerts R., Brugha T.S., Bryson H., Vollebergh W.A.M. Prevalence of mental disorders in Europe: Results from the European Study of Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrica Scandinavian 2004, 109(Suppl.):21-27.
3. Antoni M.H., Cruess S., Cruess D.G., Kumar M., Lutgendorf S., Ironson G., Kumar M. Cognitive-behavioral stress management reduces distress and 24-hour urinary free cortisol output among symptomatic HIV-infected gay men. Annals of Behavioral Medicine 2000, 22:29-37.
4. Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, Author, Washington, DC. 4th ed., Text Revision.
5. Arnsten A.F.T. Stress signaling pathways that impair prefrontal cortex structure and function. Nature Reviews Neuroscience 2009, 10:410-422.
6. Bear M.F., Connors B.W., Paradiso M.A. Neuroscience: Exploring the brain 2007, Lippincott, Williams & Wilkins, Baltimore. 3rd ed.
7. Belsky J., Jonassaint C., Pluess M., Stanton M., Brummett B., Williams R. Vulnerability genes or plasticity genes? Molecular Psychiatry 2009, 14:746-754.
8. Bessa J.M., Ferreira D., Melo I., Merques F., Cerqueira J.J., Palha J.A., Sousa N. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Molecular Psychiatry 2009, 14:764-773.
9. Bhugra D., Mastrogianni A. Globalisation and mental disorders. British Journal of Psychiatry 2004, 184:10-20.
10. Bolling M.Y., Kohlenberg R.J., Parker C.R. Behavior analysis and depression. Clinical behavior analysis 1999, 127-153. Context Press, Reno, NV. M.J. Dougher (Ed.).
11. Bowlby I. Attachment and loss: Attachment 1969, 3. Basic Books, New York.
12. Brody A.L., Saxena S., Stoessel P., Gillies L.A., Fairbanks L.A., Alborzian S., Baxter L.W. Regional brain metabolic changes in patients with major depression treated with either Paroxetine or Interpersonal Therapy. Archives of General Psychiatry 2001, 58:631-640.
13. Campbell S., Marriott M., Nahmias C., MacQueen G.M. Lower hippocampal volume in patients suffering from depression: A meta-analysis. American Journal of Psychiatry 2004, 161:598-607.
14. Carter C.S. Neuroendocrine perspectives on social attachment and love. Psychoneuroendocrinology 1998, 23:779-818.
15. Chambless D.L., Ollendick T.H. Empirically supported psychological interventions: Controversies and evidence. Annual Review of Psychology 2001, 52:685-716.
16. Chrousos G.P. Stress and disorders of the stress system. Nature Reviews Endocrinology 2009, 5:374-381.
17. Coryell W., Endicott J., Andreason N.C., Keller M.B., Clayton P.J., Hirschfield R.M., Winokur G. Depression and panic attacks: The significance of overlap as reflected in follow-up and family study data. American Journal of Psychiatry 1988, 145:293-300.
18. Cuijpers P., van Straten A., Andersson G., van Oppen P. Psychotherapy for depression in adults: A meta-analysis of comparative outcome studies. Journal of Consulting and Clinical Psychology 2008, 76:909-922.
19. de Almeida J.R.C., Versace A., Mechelli A., Hassel S., Quevedo K., Kupfer D.J., Phillips M.L. Abnormal amygdala-prefrontal effective connectivity to happy faces differentiates bipolar from major depression. Biological Psychiatry 2009, 66:451-459.
20. Debeic J., Le Doux J.E. Noradrenergic signaling in the amygdala contributes to the reconsideration of fear memory: Treatment implications for PTSD. Annals of the New York Academy of Science 2006, 1071:521-524.
21. Depue R.A., Morrone-Strupinsky J.V. A neurobehavioral model of affiliative bonding: Implications for conceptualizing a human trait of affiliation. Behavioral and Brain Sciences 2005, 28:313-350.
22. DeRubeis R.J., Gelfand L.A., Tang T.Z., Simons A.D. Medications versus cognitive behavior therapy for severely depressed outpatients: Mega-analysis of four randomized comparisons. American Journal of Psychiatry 1999, 156:1007-1013.
23. DeRubeis R.J., Hollon S.D., Amsterdam J.D., Shelton R.C., Young P.R., Salamon R.M., Gallop R. Cognitive therapy vs medications in the treatment of moderate to severe depression. Archives of General Psychiatry 2005, 62:409-416.
24. Dougher M.J., Hackbert L. A behavior-analytic account of depression and a case report using acceptance-based procedures. The Behavior Analyst 1994, 17:321-334.
25. Drevets W.C., Videen T.O., Price J.L., Preskorn S.H., Carmichael S.T., Raichle M.E. A functional anatomical study of unipolar depression. Journal of Neuroscience 1992, 12:3628-3641.
26. Druss B.G., Rosenheck R.A. Patterns of health care costs associated with depression and substance abuse in a national sample. Psychiatric Services 1999, 50:214-218.
27. Du J., Wang Y., Hunter R., Wei Y., Blumenthal R., Falke C., Manji H.K. Dynamic regulation of mitochondrial function by glucocorticoids. Proceedings of the National Academy of Sciences, USA 2009, 106:3543-3548.
28. Euler S., Schimpf H., Hennig J., Brosig B. On psychobiology in psychoanalysis: Salivary cortisol and secretory IgA as psychoanalytic process parameters. GMS Psycho-Social-Medicine 2005, 5:1-11.
29. Ferster C.B. A functional analysis of depression. American Psychologist 1973, 28:857-870.
30. Fiocco A.J., Wan N., Weekes N., Pim H., Lupien S.J. Diurnal cycle of salivary cortisol in older adult men and women with subjective complaints of memory deficits and/or depressive symptoms: Relation to cognitive functioning. Stress 2006, 9:143-152.
31. Fournier J.C., DeRubeis R.J., Hollon S.D., Dimidjian S., Amsterdam J.D., Shelton R.C., Fawcett J. Antidepressant drug effects and depression severity. Journal of the American Medical Association 2010, 303:47-53.
32. Frodl T., Meisenzahl E., Zetzsche T., Bottlender R., Born C., Groll C., Moller H.-J. Enlargement of the amygdala in patients with a first episode of major depression. Biological Psychiatry 2002, 51:708-714.
33. Frodl T., Meisenzahl E.M., Zetzsche T., Hohne T., Banac S., Schorr C., Moller H.J. Hippocampal volume and amygdala changes in patients with Major Depressive Disorder and healthy controls during a 1-year follow-up. Journal of Clinical Psychiatry 2004, 65:492-499.
34. Fu C.H.Y., Williams S.C.R., Cleare A.C., Scott J., Mitterschiffthaler M.T., Walsh N.D., Murray R.M. Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biological Psychiatry 2008, 64:505-512.
35. Fuchs E., Czeh B., Kole M.H.P., Michaelis T., Lucassen P.J. Alterations of neuroplasticity in depression: The hippocampus and beyond. European Neuropsychopharmacology 2004, 14:S481-S490.
36. Fuchs E., Flugge G., Czeh B. Remodeling of neuronal networks by stress. Frontiers in Bioscience 2006, 11:2746-2758.
37. Galynker I.I., Cai J., Ongsengg F., Finsetone H., Dutta E., Serseni D. Hypofrontality and negative symptoms in major depressive disorder. Journal of Nuclear Medicine 1998, 39:608-612.
38. Gillespie C.F., Nemeroff C.B. Hypercortisolemia and depression. Psychosomatic Medicine 2005, 67:S26-S28.
39. Glass D.C., Reim B., Singer J.E. Behavioral consequences of adaptation to controllable and uncontrollable noise. Journal of Experimental Social Psychology 1971, 7:244-257.
40. Goisman R.M., Warshaw M.G., Keller M.B. Psychosocial treatment prescriptions for generalized anxiety disorder, panic disorder, and social phobia, 1991-1996. American Journal of Psychiatry 1999, 156:1819-1821.
41. Goldapple K., Segal Z., Garson C., Lau M., Beiling P., Kennedy S., Mayberg H. Modulation of cortical-limbic pathways in major depression. Archives of General Psychiatry 2004, 61:34-41.
42. Guyton A.C., Hall J.E. Textbook of medical physiology 2006, Elsevier, Philadelphia. 11th ed.
43. Ho A.P., Gillin J.C., Buschbaum M.S., WU J.C., Abel L., Bunney W.E. Brain glucose metabolism during non-rapid eye movement sleep in major depression. Archives of General Psychiatry 1996, 53:645-652.
44. Horvath A.O., Luborsky L. The role of the therapeutic alliance in psychotherapy. Journal of Consulting and Clinical Psychology 1993, 61:561-573.
45. Hrobjartsson A., Gotzsche P.C. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. The New England Journal of Medicine 2001, 344:1594-1602.
46. Huber T.J., Issa K., Schik G., Wolf O.T. The cortisol awakening response is blunted in psychotherapy inpatients suffering from depression. Psychoneuroendocrinology 2006, 31:900-904.
47. Joels M., Baram T.Z. The neuro-symphony of stress. Nature Reviews Neuroscience 2009, 10:59-466.
48. Judd L.L., Paulus M.P., Wells K.B., Rapaport M.H. Socioeconomic burden of subsyndromal and major depression in a sample of the general population. The American Journal of Psychiatry 1996, 153:1411-1417.
49. Karssen A.M., Her S., Li J.Z., Patel P.D., Meng F., Bunney W.E., Lyons D.M. Stress-induced changes in primate prefrontal profiles of gene expression. Molecular Psychiatry 2007, 12:1089-1102.
50. Kennedy S.H., Komarski J.Z., Segal Z.V., Lau M.A., Bieling P.J., McIntyre R.S., Mayberg H.S. Differences in brain glucose metabolism between responders to CBT and Venlafaxine in a 16-week randomized control trial. American Journal of Psychiatry 2007, 164:778-788.
51. Kessler R.C., Berglund P., Borges G., Nock M., Wang P.S. Trends in suicide ideation, plans, gestures, and attempts in the United States. The Journal of the American Medical Association 2005, 293:2488-2495.
52. Kessler R.C., McGonagle K.A., Shanyang Z., Nelson C.B., Hughes M., Eshleman S., Kendler K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Archives of General Psychiatry 1994, 51:8-19.
53. Kirmayer L.J. Cultural variations in the clinical presentation of depression and anxiety: Implications for diagnosis and treatment. Journal of Clinical Psychiatry 2001, 62:22-28.
54. Kirsch P., Esslinger C., Chen Q., Mier D., Lis S., Siddhanti S., Meyer-Lindenberg A. Oxytocin modulates neural circuitry for social cognition and fear in humans. The Journal of Neuroscience 2005, 25:1489-1493.
55. Krupnick J.L., Sotsky S.M., Simmens S., Moyer J., Elkin I., Watkins J., Pilkonis P.A. The role of the therapeutic alliance in psychotherapy and pharmacotherapy outcome: Findings in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Journal of Consulting and Clinical Psychology 1996, 64:532-539.
56. Le Doux J. The emotional brain: The mysterious underpinnings of emotional life 1996, Simon & Schuster, New York.
57. Le Doux J. Emotion circuits in the brain. Annual Review of Neuroscience 2000, 23:155-184.
58. Le Doux J. Synaptic self: How our brains become who we are 2002, Viking, New York.
59. Lehto S.M., Tolmunen T., Joensuu M., Saarinen P.I., Valkonen-Korhonen M., Vanninen R., Lehtonin J. Changes in midbrain serotonin availability in atypically depressed subjects after one year of psychotherapy. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2008, 32:229-237.
60. Leichsenring F., Hiller W., Weissberg M., Leibing E. Cognitive-behavioral therapy and psychodynamic psychotherapy: Techniques, efficacy, and indications. American Journal of Psychotherapy 2006, 60:233-259.
61. Leichsenring F., Rabung S. Effectiveness of long-term psychodynamic psychotherapy: A meta-analysis. Journal of the American Medical Association 2008, 300:1551-1565.
62. Leventhal A.M., Rehm L.P. The empirical status of melancholia: Implications for psychology. Clinical Psychology Review 2005, 25:25-44.
63. Levin R.L., Heller W., Mohanty A., Herrington J.D., Miller G.A. Cognitive deficits in depression and functional specificity of regional brain activity. Cognitive Therapy & Research 2007, 31:211-233.
64. Lieberman A. Depression in Parkinson's disease: A review. Acta Neurologica Scandinavania 2006, 113:1-8.
65. Liston C., Miller M.M., Goldwater D.S., Radley J.J., Rocher A.B., Hof P.R., McEwen B.S. Stress-induced alterations in prefrontal dendritic morphology predict selective impairments in perceptual attentional set-shifting. The Journal of Neuroscience 2006, 26:7870-7874.
66. Lloyd A.J., Ferrier I.N., Barber R., Gholkar A., Young A.H., O'Brien J.T. Hippocampal volume change in depression: Late- and early-onset illness compared. British Journal of Psychiatry 2004, 184:488-495.
67. Lupien S.J., McEwen B.S., Gunnar M.R., Heim C. Effects of stress throughout the lifespan on the brain, behavior and cognition. Nature Reviews Neuroscience 2009, 10:434-445.
68. Luty S.E., Carter J.D., McKenzie J.M., Rae A.M., Frampton C.M.A., Mulder R.T., Joyce P.R. Randomized controlled trial of interpersonal psychotherapy and cognitive-behavioral therapy for depression. British Journal of Psychiatry 2007, 190:496-502.
69. Lyness J.M., Heo M., Datta C.J., Ten Have T.R., Katz I.R., Drayer R., Bruce M.L. Outcomes of minor and subsyndromal depression among elderly patients in primary care settings. Annals of Internal Medicine 2006, 144:496-504.
70. MacQueen G.M., Yucal K., Taylor V.H., Macdonald K., Joffe R. Posterior hippocampal volumes are associated with remission rates in patients with Major Depressive Disorder. Biological Psychiatry 2008, 64:880-883.
71. Maletic V., Robinson M., Oakes T., Iyengar S., Ball S.G., Russell J. Neurobiology of depression: An integrated view of key findings. International Journal of Clinical Practice 2007, 61:2030-2040.
72. Martin D.J., Garske J.P., Davis M.K. Relation of the therapeutic alliance with outcome and other variables: A meta-analytic review. Journal of Consulting and Clinical Psychology 2000, 68:348-450.
73. Martin S.D., Martin E., Rai S.S., Richardson M.A., Royall R. Brain flow changes in depressed patients treated with Interpersonal Therapy or Venlafaxine hydrochloride: Preliminary findings. Archives of General Psychiatry 2001, 58:641-648.
74. Minor T.R., Jackson R.L., Maier S.F. Effects of task-irrelevant cues and reinforcement delay on choice-escape learning following inescapable shock: Evidence for a deficit in selective attention. Journal of Experimental and Psychological Animal Behavior Processes 1984, 10:543-556.
75. Mirescu C., Gould E. Stress and adult neurogenesis. Hippocampus 2006, 16:233-238.
76. Mitra R., Ferguson D., Sapolsky R.M. SK2 potassium channel over expression in basolateral amygdala reduces anxiety, stress-induced corticosterone secretion and dendritic arborization. Molecular Psychiatry 2009, 14:847-855.
77. Mommersteeg P.M.C., Keijsers G.P.J., Heijnen C.J., Verbraak M.J.P.M., van Doornen L.J.P. Cortisol deviations in people with burnout before and after psychotherapy: A pilot study. Health Psychology 2006, 25:243-248.
78. Munetsuna E., Hattori M., Komatsu S., Sakimoto Y., Ishida A., Sakata S., Yamazaki T. Social isolation stimulates hippocampal estradiol synthesis. Biochemical and Biological Research Communications 2009, 379:480-484.
79. Murray C.J., Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study. Lancet 1997, 349:1498-1504.
80. Mykletun A., Bjerkeset O., Overland S., Prince M., Dewey M., Stewart R. Levels of anxiety and depression are predictors of mortality: The HUNT study. British Journal of Psychiatry 2009, 195:118-125.
81. Nestler E.J., Barrot M., DiLeone R.J., Elsch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34:13-25.
82. Nitschke J.B., Mackiewicz K.L. Prefrontal and anterior cingulate contributions to volition in depression. International Review of Neurobiology 2005, 67:73-94.
83. Nolte J. The human brain: An introduction to its functional anatomy 2009, Mosby Elsevier, Philadelphia, PA.
84. Nutt D. Anxiety and depression: Individual entities or two sides of the same coin? International Journal of Psychiatry in Clinical Practice 2004, 8:19-24.
85. Oken B.S. Placebo effects: Clinical aspects and neurobiology. Brain 2008, 131:2812-2823.
86. Owens M.J., Nemeroff C.B. Role of serotonin in the pathophysiology of depression: Focus on the serotonin transporter. Clinical Chemistry 1994, 40:288-295.
87. Parker G., Parker I., Brotchie H., Stuart S. Interpersonal psychotherapy for depression? The need to define its ecological niche. Journal of Affective Disorders 2006, 95:1-11.
88. Radley J.J., Sisti H.M., Hao J., Rocher A.B., McCall T., Hof P.R., Morrison J.H. Chronic behavioral stress induces induces apical dendritic reorganization in pyramidal neurons of the medial prefrontal cortex. Neuroscience 2004, 125:1-6.
89. Rang H.P., Dale M.M., Ritter J.M., Flower Rang and Dale's pharmacology 2007, Elsevier, Philadelphia, PA. 6th ed.
90. Rockliff H., Gilbert P., McEwan K., Lightman S., Glover D. A pilot exploration of heart rate variability and salivary cortisol responses to compassion-focused imagery. Clinical Neuropsychiatry 2008, 5:132-139.
91. Roozendaal B., McEwan B.S., Chattarj S. Stress, memory and the amygdala. Nature Reviews Neuroscience 2009, 10:423-433.
92. Roth A., Fonagy P. What works for whom? A critical review of psychotherapy research 2005, Guilford Press, New York. 2nd ed.
93. Rush A.J., Giles D.E., Schlesser M.A., Orsulak P.J., Weissenburger J.E., Fulton C.L., Roffwarg H.P. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression. Biological Psychiatry 1997, 41:915-928.
94. Sapolsky R.M. Stress, glucocorticoids, and damage to the nervous system: The current state of confusion. Stress 1996, 1:1-19.
95. Segerstrom S.C., Miller G.E. Psychological stress and the human immune system: A meta-analytic study of 30 years enquiry. Psychological Bulletin 2004, 130:601-630.
96. Shedler J. The efficacy of psychodynamic psychotherapy. American Psychologist 2010, 65:98-109.
97. Siegle G.J., Carter C.S., Thase M.E. Use of fMRI to predict recovery from unipolar depression with cognitive behavior therapy. American Journal of Psychiatry 2006, 163:735-738.
98. Thase M.E., Denko T. Pharmacotherapy for mood disorders. Annual Review of Clinical Psychology 2008, 4:53-91.
99. Thase M.E., Howland R.H. Biological processes in depression: An updated review and integration. Handbook of depression 1995, 213-279. Guilford Press, New York. E.E. Beckham, W.R. Leber (Eds.).
100. Thompson F., Craighead M. Innovative approaches for the treatment of depression: Targeting the HPA Axis. Neurochemistry Research 2008, 33:691-707.
101. Tops M., Riesse H., Oldehinkel A.J., Rijsdijk F.V., Ormel J. Rejection sensitivity relates to hypocortisolism and depressed mood state in young women. Psychoneuroendocrinology 2008, 33:551-559.
102. Trout D.L., Rosenfeld H.M. The effects of postural lean and body congruence on the judgment of psychotherapeutic rapport. Journal of Nonverbal Behavior 1980, 4:176-190.
103. Ustun T.B., Ayuso-Mateos J.L., Chatterji S., Mathers C., Murray C.J.L. Global burden of depressive disorders in the year 2000. British Journal of Psychiatry 2004, 184:386-392.
104. Van den Bergh B.R.H., Van Calster B., Smits T., Van Huffel S., Lagae L. Antenatal maternal anxiety is related to HPA-axis Dysregulation and self-reported depressive symptoms in adolescence: A prospective study on the fetal origins of depressed mood. Neuropsychopharmacology 2008, 33:536-545.
105. van Eijndhoven P., van Wingen G., van Oilen K., Rijpkema M., Goraj B., Verkes R.J., Tendolkar I. Amygdala volume marks the acute state in early course of depression. Biological Psychiatry 2009, 65:812-818.
106. Vythilingham M., Vermetten E., Anderson G.M., Luckenbaugh D., Anderson E.R., Snow J., Bremmer J.D. Hippocampal volume, memory, and cortisol status in Major Depressive Disorder: Effects of treatment. Biological Psychiatry 2004, 56:101-112.
107. Wampold B.E., Minami T., Tireney S.C., Baskin T.W., Bhati K.S. The placebo is powerful: Estimating placebo effects in medicine and psychotherapy from randomized clinical trials. Journal of Clinical Psychology 2005, 61:835-854.
108. Weaver I.C. Epigenetic effects of glucocorticoids. Seminars in Fetal and Neonatal Medicine 2009, 14:143-150.
109. Weaver I.C., Meaney M.J., Szyf M. Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood. Proceedings of the National Academy of Sciences, USA 2006, 103:3480-3485.
110. Whittle S., Allen N.B., Lubman D.I., Yucel M. The neurobiological basis of temperament: Towards a better understanding of psychopathology. Neuroscience and Behavioral Reviews 2006, 30:511-525.
111. Cross-national comparisons of the prevalences and correlates of mental disorders. WHO International Consortium in Psychiatric Epidemiology. Bulletin of the World Health Organisation 2001, 78:413-426. World Health Organization.
112. Yu S., Holsboer F., Almeida O.F.X. Neuronal actions of glucocorticoids: Focus on depression. Journal of Steroid Biochemistry and Molecular Biology 2008, 108:300-309.
113. Zinbarg R.E., Barlow D.H., Liebowitz M., Street E., Broadhead W.K., Roy-Byrne P., Richards J. The DSM-IV field trial for mixed anxiety-depression. American Journal of Psychiatry 1994, 151:1153-1162.